CF Industries Holdings, Inc.

Analysis of CF Industries Holdings, Inc. (CF)

Technical Analysis CF has exhibited impressive bullish momentum, outperforming the broader market by a wide margin over the past three months. Although it is trading in the upper range of its 52-week high, it still has room before reaching overbought levels. However, the significant maximum drawdown indicates notable volatility, suggesting potential for sharp pullbacks despite recent strength.

Fundamentals The company shows solid revenue growth and robust profitability, with strong margins and healthy cash flows. Financially, CF is in an excellent position with high liquidity and manageable debt levels. While operational efficiency is mixed—evidenced by a low return on assets—its core operations remain profitable and well-managed.

Valuation CF appears undervalued based on key metrics such as its low trailing and forward P/E ratios. The PEG ratio significantly below 1 signals that the stock may offer strong growth potential relative to its current valuation. However, the absence of industry peer data limits a comparative assessment of its relative attractiveness.

Risk The stock’s low beta suggests lower volatility compared to the market, yet its historical drawdown highlights meaningful downside risk. The lack of significant short interest implies limited bearish sentiment, though investors should still consider industry-specific risks, especially given the cyclical nature of fertilizer demand.

Recommendation 💡

Based on the comprehensive analysis, CF presents compelling fundamentals, attractive valuation, and strong recent momentum. While operational efficiency could improve, the company's financial health and earnings growth potential support a positive outlook. Given cyclical risks and historical volatility, patient investors may find this a worthwhile addition to a diversified portfolio. Consider Buying.

*Note: This is not investment advice, for reference only.*

RockFlow Model Forecast: Three Scenarios for 2026

Based on the analysis provided, here is a 12-month outlook for CF Industries (CF):

The outlook for CF is positive, primarily driven by its compelling valuation with a low PEG ratio and strong fundamentals, including robust profitability and a healthy balance sheet. However, the stock's performance will be highly dependent on the cyclical fertilizer market; key catalysts would be sustained high agricultural commodity prices driving farmer demand, while the main risk is an economic downturn that could suppress fertilizer demand and expose the stock's historical volatility. Given the absence of a specific analyst target, a reasonable 12-month target range could be $105-$120, reflecting its growth potential while acknowledging the sector's inherent cyclicality.

Wall Street Consensus

Most Wall Street analysts are optimistic about CF Industries Holdings, Inc.'s 12-month outlook, with consensus target around $99.54, indicating expected upside potential.

Overall, CF has investment potential but also faces challenges. Here are key factors to weigh before investing.

CF has demonstrated strong bullish momentum with significant outperformance relative to the broader market.

Over the past three months, CF has surged 24.9% with a 5.91% gain in the most recent month, outperforming the market by 19.27 percentage points. This substantial short-term performance indicates robust buying interest and suggests the stock's low beta of 0.689 has not prevented substantial upside momentum compared to market averages.

Currently trading at $97.16, CF sits approximately 75% above its 52-week low but remains about 8% below its yearly high, positioning it in the upper portion of its annual range. Despite the strong rally, the stock is not yet at extreme overbought levels given the remaining distance to its peak, though investors should note the maximum drawdown of -25.75% reflects meaningful volatility during the period.

Revenue & Profitability: CF demonstrated solid revenue growth with a sequential increase from $1.66 billion in Q3 to $1.87 billion in Q4 2025. Profitability metrics remain robust, with a consistent net income ratio improving slightly to 21.6% for the quarter, supported by a healthy operating income margin of 36.2%. The strong EBITDA margin of 48.4% underscores efficient core operations.

Financial Health: The company maintains an exceptionally strong liquidity position, evidenced by a high current ratio of 3.37 and substantial cash ratios. With a conservative debt-to-equity ratio of 0.82 and an impressive interest coverage of 16.5x, CF demonstrates minimal financial leverage risk. The negative cash conversion cycle indicates efficient working capital management, though the cash flow to debt ratio appears modest.

Operational Efficiency: Operational efficiency is mixed, with a respectable return on equity of 8.4% but a relatively low return on assets of 2.9%. The asset turnover of 0.13 suggests potentially underutilized assets, while inventory and receivables turnover metrics indicate satisfactory management of working capital components. The fixed asset turnover of 0.26 points to capital-intensive operations.

Valuation Level: The stock appears significantly undervalued based on core valuation multiples. With a trailing PE of 8.94 and a forward PE of 7.46, CF is trading at a substantial earnings discount. This undervaluation is strongly supported by a PEG ratio of approximately 0.40, which suggests robust earnings growth potential relative to its current price.

Peer Comparison: A direct comparison against industry averages is not possible due to the unavailability of industry data. Therefore, the valuation assessment relies solely on the stock's absolute multiples and the implied growth rate from its PEG ratio. The lack of industry context prevents a definitive conclusion on its relative attractiveness versus peers.

Volatility Risk: With a beta of 0.689, the stock exhibits approximately 31% less volatility than the broader market, suggesting a lower level of systematic risk. However, the 1-year maximum drawdown of -25.75% indicates a significant downside risk, implying that the stock has experienced notable price declines despite its relatively low beta.

Other Risks: The absence of short interest suggests that professional investors do not perceive a compelling near-term downside thesis for the stock. This lack of bearish sentiment, while potentially positive, does not eliminate other fundamental risks such as company-specific operational challenges or liquidity risks.